CORRECTION article

Front. Immunol., 10 September 2021

Sec. Alloimmunity and Transplantation

Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.741234

Corrigendum: Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy

  • 1. Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China

  • 2. Tianjin General Surgery Institute, Tianjin Medical University General Hospital, Tianjin, China

  • 3. Department of Anorectal Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China

Article metrics

View details

1k

Views

637

Downloads

In the original article, there was a mistake in Figure 3A as published. The figure was placed repeatedly in the process of copying/pasting our original images. The corrected Figure 3A appears below. In the original article, there was a mistake in Figure 6A as published. The figure was placed repeatedly in the process of copying/pasting our original images. The corrected Figure 6A appears below.

Figure 3

Figure 3

(A) The pseudocolor of Th1 (CD4+IFN-γ+) cells and Th17 (CD4+IL-17A+) cells in vitro.

Figure 6

Figure 6

(A) The pseudocolor of Th1 (CD4+IFN-γ+) cells, Th17 (CD4+IL-17A+) cells, and CD4+Foxp3+ Tregs in vivo.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher

Summary

Keywords

chronic allograft vasculopathy, melatonin, mesenchymal stromal cells, aorta transplantation, mice

Citation

Qin Y-f, Kong D-j, Qin H, Zhu Y-l, Li G-m, Sun C-l, Zhao Y-m, Wang H-d, Hao J-p and Wang H (2021) Corrigendum: Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy. Front. Immunol. 12:741234. doi: 10.3389/fimmu.2021.741234

Received

14 July 2021

Accepted

27 August 2021

Published

10 September 2021

Volume

12 - 2021

Edited and reviewed by

Antoine Toubert, Université Paris Diderot, France

Updates

Copyright

*Correspondence: Hao Wang, ;

†These authors share first authorship

This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics